241 Episodo

  1. Biotech Capital Markets Forecast With Allan Shaw

    Publicado: 24/1/2022

  2. Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

    Publicado: 17/1/2022

  3. Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo

    Publicado: 10/1/2022

  4. Bioengineering Human Tissue With Humacyte's Dr. Heather Prichard

    Publicado: 3/1/2022

  5. The Top Stories Of 2021 With Allan Shaw

    Publicado: 27/12/2021

  6. Complete CAR T Manufacturing Control with Cellectis' Steve Doares

    Publicado: 20/12/2021

  7. Genomically-Guided Medicine with Elevation Oncology's Shawn Leland, PharmD, RPh

    Publicado: 13/12/2021

  8. Inhalable mAbs & Vaccines with TFF's Glenn Mattes

    Publicado: 6/12/2021

  9. Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.

    Publicado: 29/11/2021

  10. Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.

    Publicado: 22/11/2021

  11. Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.

    Publicado: 15/11/2021

  12. Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.

    Publicado: 8/11/2021

  13. Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead

    Publicado: 1/11/2021

  14. The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma

    Publicado: 25/10/2021

  15. The Clinical Trials Conundrum with Allan Shaw

    Publicado: 18/10/2021

  16. CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.

    Publicado: 11/10/2021

  17. CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller

    Publicado: 4/10/2021

  18. Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.

    Publicado: 27/9/2021

  19. From Bayer To Startup Bio With AltruBio's Dr. Judy Chou

    Publicado: 20/9/2021

  20. Creating Competitive Differentiation With Allan Shaw

    Publicado: 13/9/2021

9 / 13

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Visit the podcast's native language site